Linklaters Advised EQT Healthcare Growth On The Luxembourg Legal Aspects Of Its Acquisition Of Europa Biosite
Linklaters advised EQT Healthcare Growth on the Luxembourg legal aspects of its acquisition of Europa Biosite
The Global Law firm, Linklaters has advised EQT Healthcare Growth on the Luxembourg corporate steps related to the structuring and funding of its acquisition of Europa Biosite, a leading distributor of high-quality life science reagents to academic and biopharma researchers across Europe and North America.
Headquartered in Stockholm, Europa Biosite operates across 17 countries and supports more than 60,000 researchers. The company offers access to over ten million scientific products essential to life sciences research, including antibodies, biochemicals, diagnostic kits, and ethically sourced biospecimens.
This acquisition marks the third investment in EQT Healthcare Growth’s strategy to scale profitable healthcare companies with strong growth potential.
Rémy Bonneau (Partner, Linklaters) commented,
"We are delighted to have assisted EQT and the team at EQT Healthcare Growth on the Luxembourg corporate steps enabling the closing of the acquisition of Europa Biosite, the third investment of the fund."
The Linklaters team was led by Rémy Bonneau (Partner) and Alain Farana (Counsel), with support from Sofia Lindqvist (Associate), Alexia Hervet (Associate), and Luis Gabriel Jiménez (Investment Funds Associate).
Linklaters is a British multinational law firm and a member of the "Magic Circle" of elite London-headquartered firms. It has 30 offices across 21 countries and employs over 3,100 lawyers globally. The firm is known for its expertise in complex, cross-border corporate and financial legal matters.
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.
